UNITED STATESSECURITIES AND EXCHANGE ~~COMMISSIONWashington~~COMMISSIONWASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~May~~June 1301, 2026 (~~May~~June 1201, 2026)

COMMUNITY HEALTH SYSTEMS, INC.

(Exact name of Registrant as Specified in Its Charter)


Delaware	001-15925	13-3893191
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

4000 Meridian Boulevard
Franklin, Tennessee		37067
(Address of Principal Executive Offices)		(Zip Code)

     Registrant’s Telephone Number, Including Area Code: (615) 465-7000

    

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $.01 par value	CYH	New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 52.0701 ~~Submission~~Completion of ~~Matters~~Acquisition toor aDisposition ~~Vote~~ of ~~Security Holders~~Assets.

AtOn ~~the~~June ~~Annual~~1, ~~Meeting~~2026, ofCHS/Community ~~the~~Health ~~Stockholders~~Systems, ~~(the~~Inc. (“~~Annual Meeting~~CHS”), a wholly-owned subsidiary of Community Health Systems, Inc. (the “Company”), ~~held~~completed onthe ~~May~~transactions 12contemplated by that certain Asset Purchase Agreement dated as of March 5, 2026, (the ~~Company’s~~“Purchase ~~stockholders~~Agreement”), ~~voted~~with onFreeman-Oak ~~three~~Hill ~~proposals~~Health System, ~~each~~d/b/a ofFreeman ~~which~~Health isSystem ~~described~~(the ~~more~~“Purchaser”). ~~fully~~The inentry into the ~~Company’s~~Purchase ~~Proxy~~Agreement ~~Statement~~was ~~for~~previously ~~the~~disclosed ~~Annual~~on ~~Meeting~~a Current Report on Form 8-K filed by the Company with the Securities and Exchange Commission (“SEC”) on ~~April~~March 25, 2026. ~~The~~Pursuant ~~following~~to ~~describes~~the Purchase Agreement, at the ~~matters~~closing, ~~that~~Purchaser ~~were~~acquired ~~submitted~~substantially toall of the ~~vote~~assets and assumed certain liabilities from certain subsidiaries of CHS related to (i) Northwest Medical Center - Bentonville in Bentonville, Arkansas, (ii) Northwest Medical Center - Springdale in Springdale, Arkansas, (iii) Northwest Medical Center - Willow Creek Women’s Hospital in Johnson, Arkansas, and (iv) Siloam Springs Regional Hospital in Siloam Springs, Arkansas, and the ~~stockholders~~associated ofoutpatient centers and practices (the ~~Company~~transactions atcontemplated by the ~~Annual~~Purchase ~~Meeting~~Agreement, ~~and~~the “Transaction”). The purchase price paid to CHS in connection with the ~~result~~closing of the ~~votes~~Transaction, onafter ~~these~~giving ~~matters:~~effect to estimated working capital, the assumption of finance leases by the Purchaser and before certain transaction expenses, was $110 million in cash (subject to a post-closing working capital adjustment).

(The foregoing summary of the Transaction and the terms and conditions of the Purchase Agreement is subject to, and qualified in its entirety by, the full text of the Purchase Agreement, which is attached hereto as Exhibit 2.1) and incorporated by reference herein. The ~~stockholders~~representations, ~~elected~~warranties, ~~each~~and ofcovenants contained in the ~~following~~Purchase ~~persons~~Agreement were made solely for purposes of such agreement and as aof ~~director~~specific dates, were solely for the benefit of the ~~Company~~parties ~~for~~to athe ~~term~~Purchase Agreement, may have been qualified in the Purchase Agreement by confidential disclosure schedules (which disclosure schedules may contain information that ~~expires~~modifies, atqualifies and creates exceptions to the ~~Company’s~~representations, ~~2027~~warranties ~~annual~~and ~~meeting~~covenants ofset ~~stockholders~~forth in the Purchase Agreement), may be subject to limitations and ~~until~~contractual ~~his~~risk orallocation ~~her~~mechanisms ~~respective~~agreed ~~successor~~upon ~~has~~by ~~been~~the ~~elected~~parties to the Purchase Agreement, and ~~has~~may ~~qualified:~~be subject to standards of materiality that differ from what an investor may view as material, and thus should not be relied upon as necessarily reflecting the actual state of facts or conditions.

Name	For	Against	Abstain	Broker Non-Votes
(a) Susan W. Brooks	81,095,873	2,891,262	68,228	27,004,521
(b) Lt. Gen. Ronald L. Burgess, Jr.	83,645,103	359,126	51,134	27,004,521
(c) John A. Clerico	83,505,387	497,636	52,340	27,004,521
(d) Michael Dinkins	83,513,832	490,398	51,133	27,004,521
(e) James S. Ely III	83,500,803	502,207	52,353	27,004,521
(f) John A. Fry	82,997,112	1,006,438	51,813	27,004,521
(g) Kevin J. Hammons	83,604,879	417,857	32,627	27,004,521
(h) Joseph A. Hastings, D.M.D.	83,653,444	358,347	43,572	27,004,521
(i) Elizabeth T. Hirsch	83,640,131	365,264	49,968	27,004,521
(j) William Norris Jennings, M.D.	83,228,046	778,850	48,467	27,004,521
(k) K. Ranga Krishnan, MBBS	83,223,787	766,268	65,308	27,004,521
(l) Fawn D. Lopez	83,268,829	717,430	69,104	27,004,521
(m) Wayne T. Smith	83,441,645	574,079	39,639	27,004,521
(n) H. James Williams, Ph.D.	83,599,759	404,118	51,486	27,004,521

The Transaction constituted a significant disposition for purposes of Item 2.01 of Form 8-K. Accordingly, the pro forma information required by Item 9.01 of Form 8-K is included as Exhibit 99.1 to this Current Report on Form 8-K as provided below.

~~(2) The~~Item ~~stockholders~~8.01 ~~approved~~Other ~~the non-binding advisory resolution regarding the compensation of the Company’s named executive officers:~~Events.

For		Against		Abstain		Broker Non-Votes
81,701,049		1,814,301		540,013		27,004,521

On June 1, 2026, the Company issued a press release announcing the completion of the Transaction, a copy of which press release is filed as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated herein by reference.

~~(3) The~~Item ~~stockholders~~9.01 ~~ratified~~Financial ~~the~~Statements ~~appointment~~and ~~of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026:~~Exhibits.

For		Against		Abstain		Broker Non-Votes
110,561,632		351,405		146,847		n/a

(b) Pro forma financial information

~~SIGNATURES~~The following unaudited pro forma financial information of the Company in connection with the Transaction is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference:

•

~~Pursuant~~Unaudited toPro ~~the~~Forma ~~requirements~~Condensed ofConsolidated ~~the~~Statement ~~Securities Exchange Act~~ of ~~1934,~~Loss for the ~~registrant~~three ~~has~~months ~~duly~~ended ~~caused~~March ~~this~~31, ~~report~~2026 toand bethe ~~signed~~Statement onof ~~its~~Income ~~behalf~~for by the ~~undersigned~~year ~~hereunto~~ended ~~duly~~December ~~authorized~~31, 2025.

•

			COMMUNITY HEALTH SYSTEMS, INC.(Registrant)
Date:	May 13, 2026	By:	/s/ Christopher G. Cobb
			Christopher G. CobbVice President - Legal and Corporate Secretary

Unaudited Pro Forma Condensed Consolidated Balance Sheet as of March 31, 2026.

•

Notes to the Unaudited Pro Forma Condensed Consolidated Financial Statements.

(d) Exhibits

     Exhibit 
Number

     Description

     2.1

     Purchase Agreement dated as of March 5, 2026, among CHS/Community Health Systems, Inc. and Freeman-Oak Hill Health System d/b/a Freeman Health System, as amended*


99.1		Community Health Systems, Inc. Unaudited Pro Forma Condensed Consolidated Financial Statements
99.2		Press Release of Community Health Systems, Inc. dated June 1, 2026
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


			COMMUNITY HEALTH SYSTEMS, INC. (Registrant)

Date:	June 1, 2026	By:	/s/ Kevin J. Hammons
			Kevin J. Hammons Chief Executive Officer (principal executive officer)

Filing Compare · COMMUNITY HEALTH SYSTEMS INC